The third Wednesday of November every year world chronic obstructive pulmonary disease day To raise awareness about this disease, which is estimated to be only found in Spain 11.8% of the population, Based on EPISCAN II study data released in 2020.On this date, in order to bring visibility to the progress and needs of this disease, ConSalud.es joins forces with Oaks Mesa Japan Gas Company, A special program has been launched to discuss all these topics, including “The role of innovation and change” Artificial Intelligence (AI) Fight this chronic respiratory disease.
Methods Chronic obstructive pulmonary disease (COPD) There are different challenges that must be dealt with the exacerbations that patients may suffer and the common symptoms of this pathology: chronic cough, shortness of breath, sputum production, chest pain during coughing or recurrent bronchitis. Also their quality of life and the different issues that can arise with COPD.
This pathology affects millions of people around the world and is one of the leading causes of morbidity and mortality. Experts point out that early detection and effective management of COPD are critical to improving patients’ quality of life and reducing the global burden of the disease.In the face of this disease with high mortality, new tools are needed to improve care in this area Artificial Intelligence (AI).
With devices featuring optimization and automation technology, healthcare professionals can obtain information about patient treatment in real-time
One of the big steps being taken is integrating artificial intelligence into daily life with COPD. In this way, with the help of artificial intelligence, experts recognize that patient care and monitoring of patients requiring home respiratory therapy is improving.
In this sense, companies such as Oximesa Nippon Gases have integrated information systems into the different public health services and home respiratory therapy care they provide. The entity noted that these integrations allow patient treatment information to be sent in both directions. real timewhich allows prescribers to stay informed about the progress of patient treatment, view information provided by Oximesa Nippon Gases medical staff, and more.
In addition to the rise of telematics assistance that improves monitoring and helps all patients have fast, safe, efficient and real-time control, machine learning algorithms can process clinical data, medical images and risk factors to identify patterns that may have been overlooked with traditional methods . This allows for more effective early detection, allowing for more timely medical intervention.
“We are paving the way for a future that makes COPD more preventable, detectable and manageable, giving hope to millions of people around the world”
New technologies, especially artificial intelligence, also represent other areas of treatment for COPD and other respiratory diseases, as highlighted by the GesEPOC Guidelines of the Spanish Society of Respiratory and Thoracic Pathology and the SEPAR Guidelines for Home Respiratory Therapy The advantages.As stated in a study published in the “Archivos de Bronconeumología” in February 2021, artificial intelligence through its Applications in medical imaging. “It updates current processes that slow down hospital workflow and improve physician diagnostic efficiency,” the authors note. The goal of implementing these technologies, they note, is to achieve “a more efficient and precise health system that improves people’s health.”
Furthermore, AI has proven to play a vital role in: Treatment customization Analyze personalized data to tailor management strategies to each person’s specific needs. Not only does this increase the effectiveness of the treatment, it also reduces the likelihood of unwanted side effects.Likewise, in area of researchArtificial intelligence facilitates large-scale data analysis and accelerates the discovery of new treatments and biomarkers. This will not only benefit current patients but also lay the foundation for future innovations in the prevention and treatment of COPD.
These advances enable us to achieve Personalized assistance to improve treatment compliance and avoid relapse and exacerbation. Oximesa Nippon Gases celebrates these initiatives, “By effectively integrating technology with healthcare, we are paving the way for a future where COPD is more preventable, detectable and manageable, bringing hope to millions of people around the world”.